Current Neurology and Neuroscience Reports

, Volume 11, Issue 1, pp 104–110

Neurocritical Care of a Reperfused Brain

  • Aamir Badruddin
  • Muhammad A. Taqi
  • Michael G. Abraham
  • Dhimant Dani
  • Osama O. Zaidat
Article

Abstract

Cerebral hyperperfusion and reperfusion injuries are not infrequently encountered following in reperfusion of ischemic or hypoperfused brain. Mechanism of injury could be related to tissue plasminogen activator toxicity, oxidative stress, and hyperperfusion due to impaired cerebral autoregulation in already maximally dilated cerebral vasculature and compromised cerebral hemodynamic reserve. Reperfusion injury can present as headaches and seizures in mild forms and as subarachnoid hemorrhage, intracranial hemorrhage, cerebral edema, and encephalopathy in its most severe manifestation. Prevention and identifying those at risk of hyperperfusion syndromes are the best strategy. Active treatment includes basic neurocritical care with reduction of blood pressure to a reperfused brain and timely neuroprotection and cerebral edema control measures are the mainstay of its management approach.

Keywords

Neurointervention Neurocritical care Hyperperfusion Intracranial stenting Carotid stenting Stroke thrombolysis Thrombolysis Stenting Angioplasty Critical care Stroke Reperfusion 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings [no authors listed]. N Engl J Med 1985, 312:932–936.Google Scholar
  2. 2.
    Higashida RT, Furlan AJ, Roberts H, et al.: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003, 34:e109–e137.CrossRefPubMedGoogle Scholar
  3. 3.
    Molina CA, Alvarez-Sabin J: Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 2009, 27(Suppl 1):162–167.CrossRefPubMedGoogle Scholar
  4. 4.
    Molina CA: Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke 2010, 41:842–843.CrossRefPubMedGoogle Scholar
  5. 5.
    Pan J, Konstas AA, Bateman B, et al.: Reperfusion injury following cerebral ischemia: pathophysiology, MR imaging, and potential therapies. Neuroradiology 2007, 49:93–102.CrossRefPubMedGoogle Scholar
  6. 6.
    Hussein HM, Georgiadis AL, Vazquez G, et al.: Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. AJNR Am J Neuroradiol 2010, 31:454–458.CrossRefPubMedGoogle Scholar
  7. 7.
    Molina CA, Alvarez-Sabin J, Montaner J, et al.: Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002, 33:1551–1556.CrossRefPubMedGoogle Scholar
  8. 8.
    Ribo M, Alvarez-Sabin J, Montaner J, et al.: Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006, 37:1000–1004.CrossRefPubMedGoogle Scholar
  9. 9.
    Seidel G, Cangur H, Albers T, et al.: Sonographic evaluation of hemorrhagic transformation and arterial recanalization in acute hemispheric ischemic stroke. Stroke 2009, 40:119–123.CrossRefPubMedGoogle Scholar
  10. 10.
    Aiyagari V, Badruddin A: Management of hypertension in acute stroke. Expert Rev Cardiovasc Ther 2009, 7:637–646.CrossRefPubMedGoogle Scholar
  11. 11.
    Olsen TS, Larsen B, Herning M, et al.: Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke 1983, 14:332–341.PubMedGoogle Scholar
  12. 12.
    • Yepes M, Roussel BD, Ali C, Vivien D: Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 2009, 32:48–55. This study explores the effects of tPA on the blood–brain barrier and the potential effects beyond the thrombolysis.CrossRefPubMedGoogle Scholar
  13. 13.
    •• Jung JE, Kim GS, Chen H, et al.: Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 2010, 41:172–179. This is an overview of the basic science behind reperfusion injury and potential neuroprotection strategies.CrossRefPubMedGoogle Scholar
  14. 14.
    • Kidwell CS, Latour L, Saver JL, et al.: Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis 2008, 25:338–343. This study demonstrates via imaging technique using MRI the neurotoxicity of thrombolytic therapy.CrossRefPubMedGoogle Scholar
  15. 15.
    Rosell A, Foerch C, Murata Y, Lo EH: Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir Suppl 2008, 105:173–178.CrossRefPubMedGoogle Scholar
  16. 16.
    Dominguez C, Delgado P, Vilches A, et al.: Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke 2010, 41:653–660.CrossRefPubMedGoogle Scholar
  17. 17.
    Demchuk AM, Morgenstern LB, Krieger DW, et al.: Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34–39.PubMedGoogle Scholar
  18. 18.
    Demchuk AM, Khan F, Hill MD, et al.: Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA Stroke Study. Cerebrovasc Dis 2008, 26:120–125.CrossRefPubMedGoogle Scholar
  19. 19.
    Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [no authors listed]. N Engl J Med 1995, 333:1581–1587.Google Scholar
  20. 20.
    Singer OC, Kurre W, Humpich MC, et al.: Risk assessment of symptomatic intracerebral hemorrhage after thrombolysis using DWI-ASPECTS. Stroke 2009, 40:2743–2748.CrossRefPubMedGoogle Scholar
  21. 21.
    Davis SM, Donnan GA, Parsons MW, et al.: Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7:299–309.CrossRefPubMedGoogle Scholar
  22. 22.
    • Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS: Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv 2007, 69:690–696. This clinical study provides an evidence of tight control of blood pressure following carotid stenting to less than 120 mm Hg is safe and reduces the risk of hyperperfusion syndrome.CrossRefPubMedGoogle Scholar
  23. 23.
    Morrish W, Grahovac S, Douen A, et al.: Intracranial hemorrhage after stenting and angioplasty of extracranial carotid stenosis. AJNR Am J Neuroradiol 2000, 21:1911–1916.PubMedGoogle Scholar
  24. 24.
    Ogasawara K, Sakai N, Kuroiwa T, et al.: Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg 2007, 107:1130–1136.CrossRefPubMedGoogle Scholar
  25. 25.
    Abou-Chebl A, Yadav JS, Reginelli JP, et al.: Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004, 43:1596–1601.CrossRefPubMedGoogle Scholar
  26. 26.
    Kaku Y, Yoshimura S, Kokuzawa J: Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement. AJNR Am J Neuroradiol 2004, 25:1403–1408.PubMedGoogle Scholar
  27. 27.
    Fathallah-Shaykh HM, He B, Zhao LJ, Badruddin A: Mathematical algorithm for discovering states of expression from direct genetic comparison by microarrays. Nucleic Acids Res 2004, 32:3807–3814.CrossRefPubMedGoogle Scholar
  28. 28.
    •• Medel R, Crowley RW, Dumont AS: Hyperperfusion syndrome following endovascular cerebral revascularization. Neurosurg Focus 2009, 26:E4. This study discusses and provide comprehensive review of the intracranial revascularization procedure and the clinical syndrome of hyperperfusion injury.CrossRefPubMedGoogle Scholar
  29. 29.
    Rezende MT, Spelle L, Mounayer C, et al.: Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke 2006, 37:e12–e14.CrossRefPubMedGoogle Scholar
  30. 30.
    Liu AY, Do HM, Albers GW, et al.: Hyperperfusion syndrome with hemorrhage after angioplasty for middle cerebral artery stenosis. AJNR Am J Neuroradiol 2001, 22:1597–1601.PubMedGoogle Scholar
  31. 31.
    Adams HP Jr, del Zoppo G, Alberts MJ, et al.: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007, 38:1655–1711.CrossRefPubMedGoogle Scholar
  32. 32.
    Ogasawara K, Inoue T, Kobayashi M, et al.: Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery 2004, 55:1060–1067.CrossRefPubMedGoogle Scholar
  33. 33.
    Griffin JH, Fernandez JA, Gale AJ, Mosnier LO: Activated protein C. J Thromb Haemost 2007, 5(Suppl 1):73–80.CrossRefPubMedGoogle Scholar
  34. 34.
    Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905–915.PubMedGoogle Scholar
  35. 35.
    Anderson CS, Huang Y, Arima H, et al.: Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010, 41:307–312.CrossRefPubMedGoogle Scholar
  36. 36.
    Mayer SA, Brun NC, Begtrup K, et al.: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127–2137.CrossRefPubMedGoogle Scholar
  37. 37.
    Naidech AM, Garg RK, Liebling S, et al.: Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke 2009, 40:3810–3815.CrossRefPubMedGoogle Scholar
  38. 38.
    Schneck MJ, Origitano TC: Hemicraniectomy and durotomy for malignant middle cerebral artery infarction. Neurol Clin 2006, 24:715–727.CrossRefPubMedGoogle Scholar
  39. 39.
    Hofmeijer J, Kappelle LJ, Algra A, et al., HAMLET investigators: Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009, 8:326–333.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Aamir Badruddin
    • 2
  • Muhammad A. Taqi
    • 2
  • Michael G. Abraham
    • 2
  • Dhimant Dani
    • 2
  • Osama O. Zaidat
    • 1
  1. 1.Department of Neurology, Radiology and NeurosurgeryMedical College of Wisconsin and Froedtert Hospital WestMilwaukeeUSA
  2. 2.Department of NeurologyMedical College of Wisconsin and Froedtert Hospital WestMilwaukeeUSA

Personalised recommendations